CVE-2025-0970 - Zenvia Movidesk Open Redirect Vulnerability
CVE ID : CVE-2025-0970 Published : Feb. 2, 2025, 11:15 p.m. | 2 hours, 29 minutes ago Description : A vulnerability was found in Zenvia Movidesk up to 25.01.22. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file /Account/Login. The manipulation of the argument ReturnUrl leads to open redirect. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 25.01.22.245a473c54 is able to address this issue. It is recommended to upgrade the affected component. Severity: 4.3 | MEDIUM Visit the link for more details, such as CVSS details, affected products, timeline, and more...
CVE ID : CVE-2025-0970
Published : Feb. 2, 2025, 11:15 p.m. | 2 hours, 29 minutes ago
Description : A vulnerability was found in Zenvia Movidesk up to 25.01.22. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file /Account/Login. The manipulation of the argument ReturnUrl leads to open redirect. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 25.01.22.245a473c54 is able to address this issue. It is recommended to upgrade the affected component.
Severity: 4.3 | MEDIUM
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
Published : Feb. 2, 2025, 11:15 p.m. | 2 hours, 29 minutes ago
Description : A vulnerability was found in Zenvia Movidesk up to 25.01.22. It has been declared as problematic. Affected by this vulnerability is an unknown functionality of the file /Account/Login. The manipulation of the argument ReturnUrl leads to open redirect. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 25.01.22.245a473c54 is able to address this issue. It is recommended to upgrade the affected component.
Severity: 4.3 | MEDIUM
Visit the link for more details, such as CVSS details, affected products, timeline, and more...
